Delivery Order SPE2DB22D1106-SPE2DB25FESN7
Award Date
6/9/25
Potential Completion Date
6/10/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a neurological medication, with a ceiling value of $4,648.71 and a period of performance through May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This is a $2,554.35 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TROKENDI XR 100 MG CAPSULE 30S, a prescription medication, with a performance period ending on May 30, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $2,417.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide TROKENDI XR 50 MG CAPSULE 30S, a medication, with a performance period through June 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a range of...
This is a $9,471.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TROKENDI XR 100 MG CAPSULE 30S, a prescription medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,064.50 firm fixed-price delivery order is for the supply of 4566177898 TROKENDI XR 100 MG CAPSULE 30S, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.20 firm fixed-price delivery order is for the supply of TROKENDI XR 50 MG CAPSULE 30S, a medication. The contract has an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award, valued at $2,251.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567985141 - TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trokendi XR 50 mg capsules, with a ceiling value of $1,557.85 and a completion date of June 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,153.66, is for the delivery of 4567909893 - TROKENDI XR 50 MG CAPSULE 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. This contract award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Trokendi XR 100 mg capsules, a neurological medication, with a ceiling value of $2,319.31. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...